The Electrophysiological Phenomenon of Alzheimer's Disease: A Psychopathology Theory

REFERENCES

• Anghinah, R., Kanda, A. M., Lopes, H. F., Basile, L. F. H., Machado, S., Ribeiro, P., et al. (2011). Alzheimer's disease qEEG: Spectral analysis versus coherence: Which is the best measurement? Arquivos De Neuro-Psiquiatria, 69(6), 871–874.
   PubMed Web of Science ®Google Scholar
• Alexopoulos, P., Guo, L. H., Jiang, M., Bujo, H., Grimmer, T., Förster, S., et al. (2013). Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature. Journal of Alzheimer's Disease, 36(2), 401–408.
   PubMed Web of Science ®Google Scholar
• Alzheimer's Association (AA). (2014). 2014 Alzheimer's disease: Facts and figures. Includes a special report on women and Alzheimer's disease. Alzheimer's & Dementia, 10(2), e47-e92.
   PubMedGoogle Scholar
• Berger, H. (1969). On the electroencephalogram of man. The fourteen original reports on the human electroencephalogram. Supplements to Electroencephalography and Clinical Neurophysiology 28. Amsterdam, NY: Elsevier.
   Google Scholar
• Bergman, H., Chertkow H., Wolfson, C., Stern, J., Rush, C., Whitehead, V., et al. (1997). HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. Journal of American Geriatrics Society, 45, 15–20.
   PubMed Web of Science ®Google Scholar
• Besthorn, C. Zerfass, R., Geiger-Kabisch, C., Sattel, H., Daniel, S., Schreiter-Gasser, U., et al. (1997). Discrimination of Alzheimer's disease and normal aging by EEG data. Electroencephalography and Clinical Neurophysiology, 103, 241–248.
   PubMedGoogle Scholar
• Bidzan, L., Pachalska, M., Grochmal-Bach, B., Bidzan, M., Cieslukowska, A., & Pufal, A. (2008). Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease. Medical Science Monitor, 14(9), CR473–CR479.
   Google Scholar
• Bobinski, M., de Leon, M J., Tarnawski, M., Wegiel, J., Bobinski, M., Reisberg, B., et al. (1998). Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Research, 805, 267–269.
   PubMed Web of Science ®Google Scholar
• Bosboom, P. R., Alfonso, H., & Almeida, P. (2013). Determining the predictors of change in quality of life self-ratings and carer-ratings for community-dwelling people with Alzheimer disease. Alzheimer Disease & Associated Disorders, 27, 363–371.
   PubMed Web of Science ®Google Scholar
• Brassen, S., Braus, D. F., Weber-Fahr, W., Tost, H., Moritz, S., & Adler, G. (2004). Late-onset depression with mild cognitive deficits: Electrophysiological evidences for a preclinical dementia syndrome. Dementia and Geriatric Cognitive Disorders, 18, 271–277.
   PubMed Web of Science ®Google Scholar
• Brenner, R. P., Ulrich, R. F., Spiker, D. G., Sclabassi, R. J., Reynolds, C. F., Marin, R. S., et al. (1986). Computerized EEG spectral analysis in elderly normal, demented, and depressed subjects. Electroencephalography and Clinical Neurophysiology, 64, 483–492.
   PubMedGoogle Scholar
• Breslau, J., Starr, A., Sicotte, N., Higa, J., & Buchsbaum, M. S. (1989). Topographic EEG changes with normal aging and SDAT. Electroencephalography and Clinical Neurophysiology, 72, 281–289.
   PubMedGoogle Scholar
• Carrasquillo, M. M., Khan, Q., Murray, M. E., Krishnan, S., Aakre, J., Pankratz, V. S., et al. (2014). Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. Neurology, 82(16), 1455–1462.
   PubMed Web of Science ®Google Scholar
• Chen, C. C., Hsu, C. Y., Chiu, H. W., Hu, C. J., & Lee, T. C. (2013). Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer's disease: A multicenter analysis in Taiwan. Journal of the Formosan Medical Association, S0929–6646(13), 232–235.
   Google Scholar
• Chiaramonti, R., Muscas, G. C., Paganini, M., Müller, T. J., Fallgatter, A. J., Versari, A., et al. (1997). Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type. Neuropsychobiology, 36, 153–158.
   PubMed Web of Science ®Google Scholar
• Claus, J. J., Strijers, R. L. M., Jonkman, E. J., Ongerboer de Visser, B. W., Jonker, C., Walstra, G. J. M., et al. (1999). The diagnostic value of electroencephalography in mild senile Alzheimer's disease. Clinical Neurophysiology, 110, 825–832.
   PubMed Web of Science ®Google Scholar
• Coben, L. A., Danziger, W., & Storandt, M. (1985). A longitudinal EEG study of mild senile dementia of Alzheimer type: Changes at 1 year and at 2.5 years. Electroencephalography and Clinical Neurophysiology, 61, 101–112.
   PubMedGoogle Scholar
• Courtney, C., Farrell, D., Gray, R., Hills, R., Lynch, L., Sellwood, E., et al.; AD 2000 Collaborative Group. (2004). Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomize double-blind trial. Lancet, 363(9427), 2105–1225.
   Google Scholar
• Davis, K. L., Mohs, R. C., Marin, D., Purohit, D. P., Perl, D. P., Lantz, M., et al. (1999). Cholinergic markers in elderly patients with early signs of Alzheimer disease. Journal of American Medical Association, 281, 1401–1406.
   PubMed Web of Science ®Google Scholar
• de Leon, M. J., Golomb, J., George, A. E., Convit, A., Tarshish, C. Y., McRae, T., et al. (1993). The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation. American Journal of Neuroradiology, 14, 897–906.
   PubMed Web of Science ®Google Scholar
• Desgranges, B., Baron, J.-C., de la Sayette, V., Petit-Taboué, M.-C., Benali, K., Landeau, B., et al. (1998). The neural substrates of memory systems impairment in Alzheimer's disease: A PET study of resting brain glucose utilization. Brain, 121, 611–631.
   PubMed Web of Science ®Google Scholar
• Dierks, T., Perisic, I., Frölich, L., Ihl, R., & Maurer, K. (1992). Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: Relation to severity of dementia. Psychiatry Research: Neuroimaging, 40, 181–194.
   Web of Science ®Google Scholar
• D'Onofrio, F., Salvia, S., Petretta, V., Bonavita, V., Rodriguez, G., & Tedeschi, G. (1996). Quantified-EEG in normal aging and dementias. Acta Neurologica Scandinavica, 93, 336–345.
   PubMed Web of Science ®Google Scholar
• Duffy, F. H., Albert, M. S., & McAnulty, G. (1984). Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Annals of Neurology, 16, 439–448.
   PubMed Web of Science ®Google Scholar
• Duffy, F. H., Albert, M. S., McAnulty, G., & Garvey, A. J. (1984). Age-related difference in brain electrical activity of healthy subjects. Annals of Neurology, 16, 430–438.
   PubMed Web of Science ®Google Scholar
• Fonseca, L. C., Tedrus, G. M., Fondello, M. A., Reis, I. N., & Fontoura, D. S. (2011). EEG theta and alpha reactivity on opening the eyes in the diagnosis of Alzheimer's disease. Clinical EEG and Neuroscience, 42(3), 185–189.
   PubMed Web of Science ®Google Scholar
• Fonseca, L. C., Tedrus, G. M. A. S., Prandi, L. R., & de Andrade, A. C. A. (2011). Quantitative electroencephalography power and coherence measurements in the diagnosis of mild and moderate Alzheimer's disease. Arquivos De Neuro-Psiquiatria, 69(2B), 297–303.
   PubMed Web of Science ®Google Scholar
• Förstl, H., Besthorn, C., Geiger-Kabisch, C., Sattel, H., & Schreiter-Gasser, U. (1993). Psychotic features and the course of Alzheimer's disease: Relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatrica Scandinavica, 87, 395–399.
   PubMed Web of Science ®Google Scholar
• Förstl, H., Sattel, H. Besthorn, C., Daniel, S., Geiger-Kabisch, C., Hentschel, F., et al. (1996). Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and Alzheimer's disease. British Journal of Psychiatry, 168, 280–286.
   PubMed Web of Science ®Google Scholar
• Fox, N. C., Cousens, S., Scahill, R., Harvey, R. J., & Rossor, M. N. (2000). Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: Power calculations and estimates of sample size to detect treatment effects. Archives of Neurology, 57, 339–344.
   PubMed Web of Science ®Google Scholar
• Garn, H., Waser, M., Deistler, M., Schmidt, R., Dal-Bianco, P., Ransmayr, G., et al. (2014). Quantitative EEG in Alzheimer's disease: Cognitive state, resting state and association with disease severity. International Journal of Psychophysiology, 93(3), 390–397.
   PubMed Web of Science ®Google Scholar
• Gawel, M., Zalewska, E., Szmidt-Salkowska, E., & Kowalski, J. (2009). The value of quantitative EEG in differential diagnosis of Alzheimer's disease and subcortical vascular dementia. Journal of the Neurological Sciences, 283, 127–133.
   PubMed Web of Science ®Google Scholar
• Geddes, J. W., Tekirian, T. L., Soultanian, N. S., Ashford, J. W., Davis, D. G., & Markesbery, W. R. (1997). Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiology of Aging, 18, S99-S105.
   Google Scholar
• Gélinas, I., Gauthier, L., McIntyre, M., & Gauthier, S. (1999). Development of a functional measure for persons with Alzheimer's disease: The disability assessment of dementia. American Journal of Occupational Therapy, 53, 471–481.
   PubMed Web of Science ®Google Scholar
• Gianotti, L. R., Kunig, G., Lehmann, D., Faber, P. L., Pascual-Marqui, R. D., Kochi, K., et al. (2007). Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease. Clinical Neurophysiology, 118, 186–196.
   PubMed Web of Science ®Google Scholar
• Gloor, P. (1969). Hans Berger on the electroencephalogram of man. The fourteen original reports on the human electroencephalogram. Supplements to Electroencephalography and Clinical Neurophysiology 28, 1–36. Amsterdam, NY: Elsevier.
   Google Scholar
• Grusendorf, P. (1994). EEGs in cognitive stages of Alzheimer's-type dementia. Journal of Neuroscience Nursing, 26, 42–46.
   PubMedGoogle Scholar
• Grutzendler, J., Helmin, K., Tsai, J., & Gan, W.-B. (2007). Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Annals of the New York Academy of Science, 1097(1), 30–39.
   PubMed Web of Science ®Google Scholar
• Holston, E. C. (2003). The relationship between the abnormal electrophysiological features and the degeneration in cognition, behavior, daily functioning, and global presentation manifested by individuals with Alzheimer's disease. Dissertation Abstracts International, 64(08), 3743(UMI#AAT 3100793).
   Google Scholar
• Holston, E. C. (2014). Describing brain activity of persons with AD and depressive symptoms. Archives of Psychiatric Nursing, 28(6), 413–419.
   PubMed Web of Science ®Google Scholar
• Holtzer, R., Tang, M.-X., Devanand, D. P., Albert, S. M., Wegesin, D. J., Marder, K., et al. (2003). Psychopathological features in Alzheimer's disease: Course and relationship with cognitive status. Journal of the American Geriatric Society, 51, 953–960.
   PubMed Web of Science ®Google Scholar
• Hooijer, C., Jonker, C., Posthuma, J., & Visser, S. L. (1990). Reliability, validity and follow-up of the EEG in senile dementia: Sequelae of sequential measurement. Electroencephalography and Clinical Neurophysiology, 76, 400–412.
   PubMedGoogle Scholar
• Horesh, Y., Katsel, P., Haroutunian, V., & Domany, E. (2011). Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus. European Journal of Neurology, 18, 410–424.
   PubMed Web of Science ®Google Scholar
• Ihl, R., Dierks, T., Martin, E.-M., Frölich, L., & Maurer, K. (1996). Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biological Psychiatry, 39, 319–325.
   PubMed Web of Science ®Google Scholar
• Ito, H., Shinotoh, H., Shimada, H., Miyoshi, M., Yanai, K., Okamura, N., et al. (2014). Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11c]PIB. European Journal of Nuclear Medicine and Molecular Imaging, 41(4), 745–754.
   PubMed Web of Science ®Google Scholar
• Jelic, V. & Kowalski, J. (2009). Evidence-based evaluation of diagnostic accuracy of resting EEG in dementia and mild cognitive impairment. Clinical EEG and Neuroscience, 40(2), 129–142.
   PubMed Web of Science ®Google Scholar
• Jeong, J., Kim, S. Y., & Han, S.-H. (1998). Non-linear dynamic analysis of the EEG in Alzheimer's disease with optimal embedding dimension. Electroencephalography and Clinical Neurophysiology, 106, 220–228.
   PubMedGoogle Scholar
• John, E. R. (1980). Multipotentiality: A statistical theory of brain function –evidence and implications. In Davidson R. J. & Davidson, J. M. (Eds), The psychobiology of consciousness (pp. 129–146). New York, NY: Plenum.
   Google Scholar
• John, E. R. (2002). The neurophysics of consciousness. Brain Research Reviews, 39(1), 1–28.
   Google Scholar
• John, E. R., Prichep, L. S., Fridman, J., & Easton, P. (1988). Neurometrics: Computer-assisted differential diagnosis of brain dysfunctions. Science, 239, 162–169.
   PubMed Web of Science ®Google Scholar
• Jung, H.-T., Lee, S.-H., Kim, J.-N., Lee, K.-J., & Chung, Y.-C. (2007). Quantitative electroencephalography and low resolution electromagnetic tomography imaging of Alzheimer's disease. Psychiatry Investigation, 4, 31–37.
   Google Scholar
• Kim, J.-S., Lee, S.-H., Park, G., Kim, S., Bae, S.-M., Kim, D.-W., et al. (2012). Clinical implications of quantitative electroencephalography and current source density in patients with Alzheimer's disease. Brain Topography, 25, 461–474.
   PubMed Web of Science ®Google Scholar
• Knott, V., Mohr, E., Mahoney, C., & Ilivitsky, V. (2001). Quantitative electroencephalography in Alzheimer's disease: Comparison with a control group, population norms and mental status. Journal of Psychiatry & Neuroscience, 26(2), 106–116.
   PubMed Web of Science ®Google Scholar
• Larson, C. L., Davidson, R. J., Abercrombie, H. C., Ward, R. T., Schaefer, S. M., Jackson, D. C., et al. (1998). Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power. Psychophysiology, 35, 162–169.
   PubMed Web of Science ®Google Scholar
• Lee, S.-H., Park, Y.-M., Kim, D.-W., & Im, C.-H. (2010). Global synchronization index as a biological correlate of cognitive decline in Alzheimer's disease. Neuroscience Research, 66, 333–339.
   PubMed Web of Science ®Google Scholar
• Lehtovirta, M., Partanen, J., Könönen, M., Hiltunen, J., Helisalmi, S., Hartikainen, P., et al. (2000). A longitudinal quantitative EEG study of Alzheimer's disease: Relation to Apolipoprotein E polymorphism. Dementia and Geriatric Cognitive Disorders, 11, 29–35.
   PubMed Web of Science ®Google Scholar
• Leroy, K., Menu, R., Conreur, J. L., Dayanandan, R., Lovestone, S., Anderton, B. H., et al. (2000). The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity. Federation of European Biochemical Societies: Letters, 465, 34–38.
   PubMed Web of Science ®Google Scholar
• Lim, A., Tsuang, D., Kukull, W., Nochlin, D., Leverenz, J., McCormick, W., et al. (1999). Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. Journal of American Geriatric Society, 47, 54–569.
   Google Scholar
• Liu, Y., Yu, J. T., Wang, H. F., Han, P. R., Tan, C. C., Wang, C., et al. (2014). APOE genotype and neuroimaging markers of Alzheimer's disease: Systematic review and meta analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 86(2), 127–134.
   PubMed Web of Science ®Google Scholar
• Lopez, O. L., Brenner, R. P., Becker, J. T., Ulrich, R. F., Boller, F., & DeKosky, S. T. (1997). EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology, 48, 1521–1525.
   PubMed Web of Science ®Google Scholar
• Luque-Contreras, D., Carvajal, K., Toral-Rios, D, Franco-Bocanegra, D., & Campos-Pena, V. (2014). Oxidative stress and metabolic syndrome: Cause or consequence of Alzheimer's disease? Oxidative Medicine and Cellular Longevity, DOI:10.1155/2014/497802.
   PubMed Web of Science ®Google Scholar
• Meyer, J. S., Muramatsu, K., Mortel, K. F., Obara, K., & Shirai, T. (1995). Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke, 26, 735–742.
   PubMed Web of Science ®Google Scholar
• Micanovic, C. & Pal, S. (2014). The diagnostic utility of EEG in early-onset dementia: A systematic review of the literature with narrative analysis. Journal of Neural Transmission, 121(1), 59–69.
   PubMed Web of Science ®Google Scholar
• Miller, L. J. (2007). The use of cognitive enhancers in behavioral disturbances of Alzheimer's disease. The Consultant Pharmacist, 22(9), 754–762.
   PubMedGoogle Scholar
• Millett, D. (2001). Hans Berger: From psychic energy to the EEG. Perspectives in Biology and Medicine, 44(4), 522–542.
   PubMed Web of Science ®Google Scholar
• Mody, C. K., McIntyre, H. G., Miller, B. L., Altman, K., & Read, S. (1991). Computerized EEG frequency analysis and topographic brain mapping in Alzheimer's disease. Annals of the New York Academy of Sciences, 620, 45–55.
   PubMedGoogle Scholar
• Moretti, D. V., Paternico, D., Binetti, G., Zanetti, O., & Frisoni, G. B. (2014). Theta frequency is associated to morpho-structural and perfusional modifications in subjects with mild cognitive impairment. Journal of Psychology and Psychotherapy Research, 1(1), 3–13.
   Google Scholar
• Niedermeyer, E. & Da Silva, F. L. (Eds). (1999). Electroencephalography: basic principles, clinical applications, and related fields (4th ed.). Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Nobili, F., Copello, F., Vitali, P., Prastaro, T., Carozzo, S., Pérego, G., et al. (1999). Timing of disease progression by quantitative EEG in Alzheimer's patients. Journal of Clinical Neurophysiology, 16, 566–573.
   PubMed Web of Science ®Google Scholar
• Perez, S. E., He, B., Nadeem, M., Wuu, J., Scheef, S. W., Abrahamson, E. E., et al. (2014). Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Biological Psychiatry, DOI:10.1016/j.biopsych.2013.12.016.
   Web of Science ®Google Scholar
• Pozzi, D., Petracchi, M., Sabe, L., Golimstock, A., Garcia, H., & Starkstein, S. (1995). Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease. Journal of Neuropsychiatry, 7, 61–67.
   Web of Science ®Google Scholar
• Prescott, J. W., Guidon, A., Doraiswamy, P. M., Choudhury, K. R., Liu, C., & Petrella, J.; The Alzheimer's Disease Neuroimaging Initiative. (2014). The Alzheimer structural connectome: Changes in cortical network topology with increased amyloid plaque burden. Radiology, 273(1), 175–184.
   PubMed Web of Science ®Google Scholar
• Prichep, L. S. & John, E. R. (1992). QEEG profiles of psychiatric disorders. Brain Topography, 4, 249–257.
   PubMedGoogle Scholar
• Prichep, L. S., John, E. R., Ferris, H. S., Rausch, L., Fang, Z., Cancro, R., et al. (2006). Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiology of Aging, 27, 471–481.
   PubMed Web of Science ®Google Scholar
• Prichep, L. S., John, E. R., Ferris, S. H., Reisberg, B., Almas, M., Alper, K., et al. (1994). Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiology of Aging, 15, 85–90.
   PubMed Web of Science ®Google Scholar
• Qizilbash, N., Whitehead, A., Higgins, J., Wilcock, G., Schneider, L., & Farlow, M. (1998). Cholinesterase Inhibition for Alzheimer Disease: A meta-analysis of the tacrine trials. Journal of American Medical Association, 280, 1777–1782.
   PubMed Web of Science ®Google Scholar
• Read, S. L., Miller, B. L., Mena, I., Kim, R., Itabashi, H., & Darby, A. (1995). SPECT in dementia: Clinical and pathological correlation. Journal of American Geriatrics Society, 43, 1243–1247.
   PubMed Web of Science ®Google Scholar
• Reinikainen, K. J., Riekkinen, P. J., Paljärvi, L., Soininen, H., Helkala, E.-L., Jolkkonen, J., et al. (1988). Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data. Neurochemical Research, 13, 135–146.
   PubMed Web of Science ®Google Scholar
• Reisberg, B. (1995). Senile dementia. In G. L. Maddox, R. C. Atchley, J. G. Evans, C. E. Finch, D. F. Hutlsch, R. A. Kane, et al. (Eds), The encyclopedia of aging: a comprehensive resource in gerontology and geriatrics ( 2nd ed., pp. 838–847). New York: Springer.
   Google Scholar
• Reisberg, B., Kenowsky, S., Franssen, E. H., Auer, St. R., & Souren, L. E. M. (1999). President's report. Towards a science of Alzheimer's disease management: A model based upon current knowledge of retrogenesis. International Psychogeriatrics, 11, 7–23.
   PubMedGoogle Scholar
• Reisberg, B. & Kluger, A. (1998). Assessing the progression of dementia: Diagnostic considerations. In C. Salzman (Ed.), Clinical geriatric psychopharmacology ( 3rd ed., pp. 432–462). Baltimore: Williams & Wilkins.
   Google Scholar
• Robinson, D. J., Merskey, H., Blume, W. T., Fry, R., Williamson, P. C., & Hachinski, V. C. (1994). Electroencephalography as an aid in the exclusion of Alzheimer's disease. Archives of Neurology, 51, 280–284.
   PubMed Web of Science ®Google Scholar
• Rochat, L., Billieux, J., Van der Linden, A.-C. J., Annoni, J.-M., Zekry, D., Gold, G., et al. (2013). A multidimensional approach to impulsivity changes in mild Alzheimer's disease and control participants: Cognitive correlates. Cortex, 49(1), 90–100.
   PubMed Web of Science ®Google Scholar
• Rodriguez, R., Lopera, F., Alvarez, A., Fernandez, Y., Galan, L., Quiroz, Y., et al. (2014). Spectral analysis of EEG in familial Alzheimer's disease with E280A Presenilin-1 mutation gene. International Journal of Alzheimer's Disease, DOI:10.1155/2014/180741.
   PubMedGoogle Scholar
• Samuel, W., Caligiuri, M., Galasko, D., Lacro, J., Marini, M., McClure, F. S., et al. (2000). Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. International Journal of Geriatric Psychiatry, 15, 794–802.
   PubMed Web of Science ®Google Scholar
• Signorino, M., Pucci, E., Brizioli, E., Cacchio, G., Nolfe, G., & Angeleri, F. (1996). EEG power spectrum typical of vascular dementia in a subgroup of Alzheimer patients. Archives of Gerontology and Geriatrics, 23, 139–151.
   PubMed Web of Science ®Google Scholar
• Soininen, H., Reinikainen, K. J., Partanen, J., Helkala, E.-L., Paljärvi, L., & Riekkinen, P. J. (1992). Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease. Neuroscience, 49, 529–535.
   PubMed Web of Science ®Google Scholar
• Solodkin, A., Chen, E. E., Van Hoesen, G. W., Heimer, L., Shereen, A., Kruggel, F., et al. (2013). In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease. Journal of Comparative Neurology, 521(18), 4300–4317.
   PubMed Web of Science ®Google Scholar
• Szelies, B., Mielke, R., Herholz, K., & Heiss, A. W. D. (1994). Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia. Electroencephalography & Clinical Neurophysiology, 91, 131–139.
   PubMedGoogle Scholar
• Teng, E., Lu, P. H., & Cummings, J. (2007). Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 24, 253–259.
   PubMed Web of Science ®Google Scholar
• Tejada-Vera, B. (2013). Mortality from Alzheimer's disease in the United States: Data for 2000 and 2010. NCHS Data Brief, No. 116. Hyattsville, MD: National Center for Health Statistics.
   Google Scholar
• Tractenberg, R. E. W., Weiner, M. F., Cummings, J. L., Patterson, M. B., & Thal, L. J. (2005). Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: A factor analytic approach. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 51–60.
   PubMed Web of Science ®Google Scholar
• Valdés, P., Valdés, M., Carballo, J. A., Alvarez, A., Díaz, G. F., Biscay, R., et al. (1992). QEEG in a public health system. Brain Topography, 4, 259–266.
   PubMedGoogle Scholar
• Valladares-Neto, D. C., Buchsbaum, M. S., Evans, W. J., Nguyen, D., Nguyen, P., Siegel, B. V., et al. (1995). EEG delta, positron emission tomography, and memory deficits in Alzheimer's disease. Neuropsychobiology, 31, 173–181.
   PubMed Web of Science ®Google Scholar
• Velasques, B., Machado, S., Paes, F., Cunha, M., Sanfim, A., et al. (2011). Sensorimotor integration and psychopathology: Motor control abnormalities related to psychiatric disorders. World Journal of Biological Psychiatry, 12, 560–573.
   PubMed Web of Science ®Google Scholar
• Wszolek, Z. K., Herkes, G. K., Lagerlund, T. D., & Kokmen, E. (1992). Comparison of EEG background frequency analysis, psychologic test scores, short test of mental status, and quantitative SPECT in dementia. Journal of Geriatric Psychiatry and Neurology, 5, 22–30.
   PubMedGoogle Scholar
• Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., et al.; Alzheimer's Disease Neuroimaging Initiative. (2012). Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. Plos One, 7(10), e47905.
   PubMed Web of Science ®Google Scholar
• Zahodne, L. B., Devanand, D. P., & Stern, Y. (2013). Coupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptoms. Journal of Alzheimer's Disease, 34, 851–860.
   PubMed Web of Science ®Google Scholar
• Zahodne, L. B., Ornstein, K., Cosentino, S., Devanand, D. P., & Stern, Y. (2013). Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression. American Journal of Geriatric Psychiatry, 23(2), 130–140.
   PubMed Web of Science ®Google Scholar
• Zdanys, K. F., Kleiman, T. G., MacAvoy, M. G., Black, B. T., Rightmer, T. E., Grey, M., et al. (2007). Apolipoprotein E E4 allele increases risk for psychotic symptoms in Alzheimer's disease. Neuropsychopharmacology, 32, 171–179.
   PubMed Web of Science ®Google Scholar